16th Nov 2026 07:00
![]()
Tristel plc
(“Tristel” or the “Company”)
Notice of Annual General Meeting and Posting of Annual Report
Directorate change
Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that the Notice of Annual General Meeting ("AGM") and the 2026 Annual Report and Accounts for the year ended 30 June 2026 will be posted to shareholders today and are available to download from the investor section of Company's website here.
The Company's AGM will take place on Thursday, 10 December 2026 at 11.00am at their offices at Unit 1b, Lynx Business Park, Fordham Road, Snailwell, Newmarket, Cambridgeshire CB8 7NY.
The Company also announces that after nine years on the Board, Tom Jenkins, Non-Executive Director, will not be standing for re-election at the forthcoming AGM, having reached the end of his tenure. He will step down from the Board at the conclusion of the meeting. The Board would like to express its sincere thanks to Tom for his dedication, support and valuable contribution to the Company and wish him well in the future.
The Company intends to appoint a new independent Non-Executive Director in due course.
For further information please contact:
Tristel plc | Via Walbrook PR | |||
Chris Lee, Chief Executive Officer Anna Wasyl, Chief Financial Officer | https://investors.tristel.com/ | |||
|
| |||
Walbrook PR Ltd | Tel: 020 7933 8780 or [email protected] | |||
Paul McManus / Anna Dunphy / Rachel Broad | Mob: 07980 541 893/ 07876 741 001 / 07747 515 393 | |||
|
| |||
Cavendish Capital Markets Ltd | Tel: 020 7220 0500 | |||
Geoff Nash / Callum Davidson / Joe Smith (Corporate Finance) |
| |||
Sunila de Silva (Corporate Broking) / Louise Talbot (Sales) |
| |||

About Tristel plc
Tristel plc is a global infection prevention company focused on the manufacture and supply of products using its unique proprietary chlorine dioxide (ClO2) chemistry. The Company is a market leader in manual decontamination of medical devices, supplying hospitals with products under the Tristel brand, which also encompasses its sporicidal surface disinfection range offered as a sustainable alternative to commonly used pre-wetted plastic wipe.
Tristel’s head office and manufacturing facility is located in Snailwell, near Cambridge, and operates globally employing approximately 280 people across 16 subsidiaries selling into 40+ countries. The Company targets double digit revenue growth annually and an adjusted EBITDA margin of at least 25% and the business is profitable, with no debt and has a progressive dividend policy.
The Company has been listed on the London Stock Exchange’s AIM market since 2005 (AIM: TSTL).
For more information about Tristel’s product range please visit: https://tristel.com
Related Shares:
Tristel